Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Leslie Meltzer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- A. Sinclair Dunlop - $2.15M of APLS open-market activity in the last 12 months
- Timothy Eugene Sullivan - $1.84M of APLS open-market activity in the last 12 months
- David O. Watson - $1.34M of APLS open-market activity in the last 12 months
- Cedric Francois - $980K of APLS open-market activity in the last 12 months
- Nur Nicholson - $270K of APLS open-market activity in the last 12 months
- Pascal Deschatelets - $198K of APLS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Leslie Meltzer?
Leslie Meltzer is a corporate insider, tracked as Chief Research and Development of Apellis Pharmaceuticals, Inc. (APLS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Leslie Meltzer last file a Form 4?
The most recent primary Form 4 on record is dated 14 May 2026, one of 3 filings going back to 2025.
Where can I see all of Leslie Meltzer's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Leslie Meltzer and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
